Carney Edward W, Kimmel Carole A
Toxicology & Environmental Research and Consulting, The Dow Chemical Company, Midland, Michigan 48674, USA.
Birth Defects Res B Dev Reprod Toxicol. 2007 Dec;80(6):473-96. doi: 10.1002/bdrb.20133.
Delayed (or incomplete) ossification of developing fetal bones and wavy ribs are some of the most common skeletal variations encountered in regulatory guideline developmental toxicity studies. Although they tend to be regarded as minor effects, they can be quite sensitive and consequently may influence the study lowest-observed-adverse-effect levels (LOAELs), and thus, impact classification, labeling, and risk assessment. In this study, we review the underlying mechanisms of these skeletal variations, evaluate different scenarios in which they have been observed, offer guidance for their interpretation, and comment on their use for risk assessment. Both minor delays in ossification and wavy ribs seem to be readily repairable via postnatal skeletal remodeling, are not mechanistically linked to malformation, and often are seen in the presence of maternal or fetal toxicity. As such, these minor variations would not generally be considered adverse in and of themselves but should be interpreted in the context of other maternal and fetal findings, information available on normal skeletogenesis patterns, mode of action of the test agent, and historical control incidence using a weight of evidence approach.
发育中胎儿骨骼的延迟(或不完全)骨化以及肋骨弯曲是监管指南发育毒性研究中最常见的一些骨骼变异。尽管它们往往被视为轻微影响,但可能相当敏感,因此可能会影响研究的最低观察到有害作用水平(LOAEL),进而影响分类、标签和风险评估。在本研究中,我们回顾了这些骨骼变异的潜在机制,评估了观察到它们的不同情况,为其解读提供指导,并对其在风险评估中的应用进行评论。骨化的轻微延迟和肋骨弯曲似乎都可通过出生后骨骼重塑轻易修复,与畸形没有机制上的联系,并且常在存在母体或胎儿毒性的情况下出现。因此,这些轻微变异本身一般不会被视为有害,但应结合其他母体和胎儿发现、正常骨骼发生模式的可用信息、受试物的作用方式以及使用证据权重方法的历史对照发生率来进行解读。